Abstract:In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where long-term survival is a critical outcome. These therapies, including immunotherapies or other advanced treatments, aim to establish durable effects. They often exhibit distinct survival patterns such as crossing or delayed separation and potentially leveling-off at the tails of survival curves, clearly violating the proportional hazards assumption and rendering the hazard ratio inappropriate for measuring treatment effects. The proposed methodology utilizes the mixture cure framework to separately analyze the cure rates of long-term survivors and the survival functions of susceptible individuals. We evaluate a nonparametric estimator for the susceptible survival function in the one-sample setting. Under sufficient follow-up, it is expressed as a location-scale-shift variant of the Kaplan-Meier (KM) estimator. It retains several desirable features of the KM estimator, including inverse-probability-censoring weighting, product-limit estimation, self-consistency, and nonparametric efficiency. In scenarios of insufficient follow-up, it can easily be adapted by incorporating a suitable cure rate estimator. In the two-sample setting, besides using the difference in cure rates to measure the long-term effect, we propose a graphical estimand to compare the relative treatment effects on susceptible subgroups. This process, inspired by Kendall's tau, compares the order of survival times among susceptible individuals. The proposed methods' large-sample properties are derived for further inference, and the finite-sample properties are examined through extensive simulation studies. The proposed methodology is applied to analyze the digitized data from the CheckMate 067 immunotherapy clinical trial.

Statistical Inference for Data-adaptive Doubly Robust Estimators with Survival Outcomes

Doubly robust estimators for generalizing treatment effects on survival outcomes from randomized controlled trials to a target population

Doubly robust estimation of optimal treatment regimes for survival data using an instrumental variable

Intervention treatment distributions that depend on the observed treatment process and model double robustness in causal survival analysis

Double robust estimation of partially adaptive treatment strategies

Doubly Robust Nonparametric Instrumental Variable Estimators for Survival Outcomes

Estimand-based Inference in Presence of Long-Term Survivors

Doubly Robust Semiparametric Inference Using Regularized Calibrated Estimation with High-dimensional Data

Double Robust Variance Estimation

A NEW PERSPECTIVE ON ROBUST M-ESTIMATION: FINITE SAMPLE THEORY AND APPLICATIONS TO DEPENDENCE-ADJUSTED MULTIPLE TESTING

Asymptotic Theory for Doubly Robust Estimators with Continuous-Time Nuisance Parameters

Estimating Heterogenous Treatment Effects for Survival Data with Doubly Doubly Robust Estimator

Enhanced doubly robust estimation with concave link functions for estimands in clinical trials

Double robust estimation of functional outcomes with data missing at random

Regularized Bidimensional Estimation of the Hazard Rate

Propensity weighting plus adjustment in proportional hazards model is not doubly robust

The Bias-Variance Tradeoff of Doubly Robust Estimator with Targeted $L_1$ regularized Neural Networks Predictions

Asymptotic equivalence and adaptive estimation for robust nonparametric regression

An Efficient Doubly-robust Imputation Framework for Longitudinal Dropout, with an Application to an Alzheimer's Clinical Trial

Relaxed Doubly Robust Estimation in Causal Inference

Optimality of testing procedures for survival data